KBC Group NV Cuts Position in Cigna Group $CI

KBC Group NV reduced its position in Cigna Group (NYSE:CIFree Report) by 0.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 357,056 shares of the health services provider’s stock after selling 2,180 shares during the period. KBC Group NV owned approximately 0.13% of Cigna Group worth $95,245,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC increased its position in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares in the last quarter. Sivia Capital Partners LLC raised its stake in shares of Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after acquiring an additional 109 shares during the period. NewEdge Advisors LLC lifted its holdings in shares of Cigna Group by 4.5% during the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after acquiring an additional 958 shares in the last quarter. Treasurer of the State of North Carolina lifted its holdings in shares of Cigna Group by 16.6% during the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after acquiring an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. purchased a new stake in Cigna Group during the 2nd quarter worth $163,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Ratings Changes

CI has been the subject of several recent research reports. Piper Sandler lowered their price target on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. Guggenheim increased their target price on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and dropped their target price for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Finally, The Goldman Sachs Group boosted their price target on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.

View Our Latest Research Report on Cigna Group

Cigna Group Stock Performance

Cigna Group stock opened at $281.72 on Monday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a market capitalization of $74.52 billion, a price-to-earnings ratio of 11.94, a price-to-earnings-growth ratio of 1.08 and a beta of 0.29. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The firm’s fifty day moving average price is $286.68 and its 200 day moving average price is $280.43.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were paid a $1.56 dividend. The ex-dividend date was Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is 26.45%.

Insider Transactions at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.60% of the company’s stock.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.